NO20013015L - Liposominfluminsyre - ny transdermal antiinflammatorisk medisin - Google Patents

Liposominfluminsyre - ny transdermal antiinflammatorisk medisin

Info

Publication number
NO20013015L
NO20013015L NO20013015A NO20013015A NO20013015L NO 20013015 L NO20013015 L NO 20013015L NO 20013015 A NO20013015 A NO 20013015A NO 20013015 A NO20013015 A NO 20013015A NO 20013015 L NO20013015 L NO 20013015L
Authority
NO
Norway
Prior art keywords
inflammatory
drug
liposomine
acid
new transdermal
Prior art date
Application number
NO20013015A
Other languages
English (en)
Other versions
NO20013015D0 (no
Inventor
Konstantinos Demetzos
Helen Kammenou
Michalis Rallis
Georgios Papaioannou
Aristidis Georgopoulos
Georgios Tsamouris
Sofia Hatziantoniou
Georgios Giannisis
Georgios Nounesis
Christina Savva Dimopoulou
Original Assignee
P N Gerolymatos Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by P N Gerolymatos Sa filed Critical P N Gerolymatos Sa
Publication of NO20013015D0 publication Critical patent/NO20013015D0/no
Publication of NO20013015L publication Critical patent/NO20013015L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A61K9/1278—Post-loading, e.g. by ion or pH gradient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Innkapsling av medikamentet nifluminsyre i liposomer i den hensikt å danne en ny transdermal ikke-steroid anti-inflammatorisk formulering. Nifluminsyre så vel som dens esterderivater er blitt innkapslet i liposomer med ulike liposomformuleringer for å oppnå økt effektivitet av den aktive forbindelse. Limposomsuspensjonen, med eller uten innkapslet medikament, er blitt formulert som en krem og en stabilitetsstudie av den endelige formulering er blitt utført.
NO20013015A 1998-12-24 2001-06-18 Liposominfluminsyre - ny transdermal antiinflammatorisk medisin NO20013015L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GR98100469 1998-12-24
PCT/GR1999/000048 WO2000038681A1 (en) 1998-12-24 1999-12-22 Liposomic niflumic acid - new transdermal anti-inflammatory medicine

Publications (2)

Publication Number Publication Date
NO20013015D0 NO20013015D0 (no) 2001-06-18
NO20013015L true NO20013015L (no) 2001-06-18

Family

ID=10943556

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013015A NO20013015L (no) 1998-12-24 2001-06-18 Liposominfluminsyre - ny transdermal antiinflammatorisk medisin

Country Status (17)

Country Link
EP (1) EP1140089A1 (no)
JP (1) JP2002533394A (no)
KR (1) KR20010089889A (no)
CN (1) CN1331592A (no)
AU (1) AU1673400A (no)
BR (1) BR9917006A (no)
CA (1) CA2357765A1 (no)
CZ (1) CZ20012240A3 (no)
GR (1) GR1003359B (no)
HU (1) HUP0104853A3 (no)
IL (1) IL143499A0 (no)
IS (1) IS5964A (no)
MX (1) MXPA01006462A (no)
NO (1) NO20013015L (no)
PL (1) PL349344A1 (no)
SK (1) SK7962001A3 (no)
WO (1) WO2000038681A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040170677A1 (en) * 2002-11-26 2004-09-02 Ning Hu Method of drug loading in liposomes by gradient
BRPI0409663A (pt) 2003-04-25 2006-04-18 Penn State Res Found método e sistema para o envio sistêmico de compostos bioativos derivados de lipìdeo de detenção de crescimento
US20050255154A1 (en) 2004-05-11 2005-11-17 Lena Pereswetoff-Morath Method and composition for treating rhinitis
JP4791082B2 (ja) * 2005-05-30 2011-10-12 株式会社クラレ リポソームおよびそれを含む皮膚外用剤
JP4931369B2 (ja) * 2005-05-31 2012-05-16 ポーラ化成工業株式会社 リポソームおよびそれを含む処置用の組成物
MX2007015577A (es) 2005-06-09 2008-02-25 Biolipox Ab Metodo y composiciones para el tratamiento de trastornos inflamatorios.
US20120028335A1 (en) 2010-07-28 2012-02-02 Life Technologies Corporation Anti-viral azide-containing compounds
US20130209550A1 (en) 2010-07-28 2013-08-15 Life Technologies Corporation Anti-Viral Azide Containing Compounds
CN108977412A (zh) 2012-01-26 2018-12-11 生命科技公司 用于提高病毒感染性的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4528193A (en) * 1978-12-27 1985-07-09 A. Natterman & Cie. Gmbh Inflammation-preventing pharmaceutical composition of oral administration
DE3683606D1 (de) * 1985-11-27 1992-03-05 Ethicon Inc Hemmung der postoperativen adhaesionsbildung durch topische verabreichung eines entzuendungshemmenden nichtsteroiden wirkstoffs.
CA1320130C (en) * 1986-06-12 1993-07-13 Alan L. Weiner Methods and compositions using liposome-encapsulated non-steroidal anti-inflammatory drugs
DE69632859T2 (de) * 1995-04-18 2005-07-14 Yissum Research Development Company Of The Hebrew University Of Jerusalem Verfahren zur Arzneistoffbehandlung von Liposomen Zusammensetzung

Also Published As

Publication number Publication date
PL349344A1 (en) 2002-07-15
CA2357765A1 (en) 2000-07-06
HUP0104853A3 (en) 2003-05-28
NO20013015D0 (no) 2001-06-18
AU1673400A (en) 2000-07-31
IS5964A (is) 2001-06-08
CN1331592A (zh) 2002-01-16
EP1140089A1 (en) 2001-10-10
BR9917006A (pt) 2001-10-30
KR20010089889A (ko) 2001-10-12
MXPA01006462A (es) 2002-06-04
SK7962001A3 (en) 2002-02-05
GR1003359B (el) 2000-04-10
HUP0104853A2 (hu) 2002-05-29
CZ20012240A3 (cs) 2001-11-14
IL143499A0 (en) 2002-04-21
JP2002533394A (ja) 2002-10-08
WO2000038681A1 (en) 2000-07-06

Similar Documents

Publication Publication Date Title
ATE427925T1 (de) Phenoxycarbonsaureverbindungen und zusammensetzungen zur verabreichung aktiver wirkstoffe
PT801649E (pt) Derivados de hidroxilamina uteis para aumentar a producao de proteinas moleculares adventicias e sua preparacao
EA200001154A1 (ru) Твердые композиции, содержащие производные гамма-аминомасляной кислоты, и способ их получения
NO863061L (no) Fremgangsmaate for fremstilling av fysiologisk aktive fenoksyeddiksyrederivater.
ATE13286T1 (de) Pharmazeutisch aktive phenylcarbonsaeurederivate.
NO863636L (no) Fremgangsmaate for fremstilling av transdermalt resorberbare preparater av arylpropionsyrederivater.
NO20013015L (no) Liposominfluminsyre - ny transdermal antiinflammatorisk medisin
ATE447397T1 (de) Darreichungsform mit erhöhter bioverfügbarkeit
ATE250034T1 (de) Pyridylverbindungen und diese enthaltende pharmazeutische zubereitungen
NO20022201L (no) Lösninger inneholdende Epinastin
ATE335807T1 (de) Neuer stamm von milchsäurebakterien und diesen enthaltende essbare zusammensetzungen, wirkstoffe und tierische arzneimittel
FI940696A (fi) Uudet pyratsiinijohdannaiset, niiden valmistus ja käyttö
TNSN97134A1 (fr) Comprime de maleate de trimebutine pellicule
TR199802573A2 (xx) Bir etken madde i�eren ��kelmi� silisler.
DE60019086D1 (de) Zusammensetzungen zur behandlung von hautkrankheiten
EP0104768A3 (en) Oral compositions comprising ng-acyl derivatives of arginine
NO980058L (no) Opthalmiske preparater
FI862806A0 (fi) Medel foer foerhindrande av elastosis.
DE60302951D1 (de) Pyroglutaminsäure-salz von Amlodipin
DK1202956T3 (da) Terapeutisk og/eller ernærngsmæssigt forstærkede derivater af aktive bestanddele og oralt indgivelsesbare præparater indeholdende de samme
EP1149832A4 (en) BENZAMIDE DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING THEM
HUP9702348A2 (hu) Új, véralvadásgátló hatású glikozidok és az ezeket tartalmazó gyógyszerkészítmények
PT1005275E (pt) Formulacao inibidora e profilactica
DE60135845D1 (de) Pralmorelin-haltige nasentropfen-präparate
MEP18508A (en) Pharmaceutical composition and preparation thereof

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application